MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
2019 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
54.4 M |
Market Cap[1] |
$ 249 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Evelo Biosciences
EVLO
|
- | -14.46 % | $ 27.9 M | Nasdaq Global Select Market | USA |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
- | -15.15 % | $ 60.3 M | Nasdaq Global Select Market |  Britain |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Albireo Pharma
ALBO
|
- | -0.23 % | $ 916 M | Nasdaq Capital Market | USA |
 |
Allakos
ALLK
|
- | - | $ 28.6 M | Nasdaq Global Select Market,SPB | USA |
 |
Allena Pharmaceuticals
ALNA
|
- | 3.16 % | $ 1.9 M | Nasdaq Global Select Market | USA |
 |
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | USA |
 |
Фармсинтез
LIFE
|
- | - | - | MOEX |  Russia |
 |
Lipocine
LPCN
|
$ 2.37 | 1.24 % | $ 12.9 M | Nasdaq Global Select Market | USA |
 |
Ayala Pharmaceuticals
AYLA
|
- | - | $ 7.46 M | Nasdaq Global Market |  Israel |
 |
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | USA |
 |
Amryt Pharma plc
AMYT
|
- | - | $ 621 M | Nasdaq Global Select Market | Britain |
 |
Aridis Pharmaceuticals
ARDS
|
- | 17.91 % | $ 11.1 M | Nasdaq Capital Market | USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
- | -14.27 % | $ 1.7 M | Nasdaq Global Market |  Singapore |
 |
Athersys
ATHX
|
- | 3.77 % | $ 22.4 M | Nasdaq Capital Market | USA |
 |
Liquidia Corporation
LQDA
|
$ 68.3 | 0.5 % | $ 5.88 B | Nasdaq Capital Market | USA |
|
Larimar Therapeutics
LRMR
|
$ 3.85 | 0.39 % | $ 320 M | Nasdaq Global Market | USA |
 |
Lexicon Pharmaceuticals
LXRX
|
$ 2.23 | 0.89 % | $ 810 M | Nasdaq Global Select Market | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
$ 5.18 | 0.58 % | $ 992 M | Nasdaq Global Select Market |  Canada |
 |
Mustang Bio
MBIO
|
$ 0.54 | 3.28 % | $ 2.65 M | Nasdaq Global Market | USA |
 |
Moleculin Biotech
MBRX
|
$ 0.79 | 10.58 % | $ 936 K | Nasdaq Global Select Market | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
$ 27.96 | 0.57 % | $ 4.71 B | Nasdaq Global Select Market,SPB | USA |
 |
Seres Therapeutics
MCRB
|
$ 5.71 | 1.42 % | $ 50.6 M | Nasdaq Global Select Market | USA |
 |
Mesoblast Limited
MESO
|
$ 16.59 | 1.05 % | $ 20 B | Nasdaq Global Select Market |  Australia |
 |
MacroGenics
MGNX
|
$ 4.31 | 3.53 % | $ 272 M | Nasdaq Global Select Market | USA |
 |
MeiraGTx Holdings plc
MGTX
|
$ 13.55 | 0.5 % | $ 1.09 B | Nasdaq Global Select Market | USA |
 |
Mirum Pharmaceuticals
MIRM
|
$ 100.89 | 0.27 % | $ 5.06 B | Nasdaq Global Select Market | USA |
 |
Milestone Pharmaceuticals
MIST
|
$ 1.16 | 0.41 % | $ 123 M | Nasdaq Global Select Market | Canada |
 |
Achieve Life Sciences
ACHV
|
$ 8.2 | 2.17 % | $ 357 M | Nasdaq Capital Market | USA |
 |
MannKind Corporation
MNKD
|
$ 4.28 | 5.39 % | $ 1.31 B | Nasdaq Global Market | USA |
 |
MediciNova
MNOV
|
$ 1.71 | 4.91 % | $ 83.9 M | Nasdaq Global Market | USA |
|
Monopar Therapeutics
MNPR
|
$ 116.08 | 0.38 % | $ 860 M | Nasdaq Global Select Market | USA |
 |
Merck & Co.
MRK
|
$ 149.29 | 0.46 % | $ 374 B | NYSE,SPB | USA |
 |
Marker Therapeutics
MRKR
|
$ 1.26 | 6.78 % | $ 19.3 M | Nasdaq Global Market | USA |
 |
Moderna
MRNA
|
$ 144.37 | 9.93 % | $ 56.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Matinas BioPharma Holdings
MTNB
|
$ 0.19 | 1.65 % | $ 1.04 M | NYSE American | USA |
 |
Adagene
ADAG
|
$ 3.58 | 0.06 % | $ 211 M | Nasdaq Global Market |  China |
 |
Minerva Neurosciences
NERV
|
$ 4.39 | 1.17 % | $ 37.2 M | Nasdaq Global Market | USA |
 |
Nektar Therapeutics
NKTR
|
$ 75.62 | 1.93 % | $ 1.28 B | Nasdaq Global Select Market,SPB | USA |
 |
Nkarta
NKTX
|
$ 2.92 | 4.66 % | $ 216 M | Nasdaq Global Select Market | USA |
 |
NanoViricides
NNVC
|
$ 1.11 | 0.43 % | $ 16.8 M | NYSE American | USA |
 |
Nurix Therapeutics
NRIX
|
$ 26.18 | 0.15 % | $ 2.27 B | Nasdaq Global Select Market,SPB | USA |
 |
Intellia Therapeutics
NTLA
|
$ 12.68 | 0.47 % | $ 1.37 B | Nasdaq Global Market,SPB | USA |
 |
Novavax
NVAX
|
$ 10.18 | 2.22 % | $ 1.65 B | Nasdaq Global Select Market | USA |
 |
Novartis AG
NVS
|
$ 139.08 | 0.39 % | $ 270 B | NYSE |  Schweiz |
 |
NextCure
NXTC
|
$ 7.9 | 1.02 % | $ 22.5 M | Nasdaq Global Select Market | USA |
 |
Ocugen
OCGN
|
$ 1.35 | 0.74 % | $ 422 M | Nasdaq Capital Market | USA |
 |
Ocular Therapeutix
OCUL
|
$ 10.9 | 2.44 % | $ 2.04 B | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.